|
|
|
Search published articles |
|
|
Showing 2 results for Alijani
Akram Alijani, Rahmatoolah Parandin , Namdar Yousofvand , Shahrbanoo Oryan , Volume 18, Issue 1 (spring 2018)
Abstract
CT
Background & objectives: So far, various reports have been presented on the relationship between sex hormones and gender-related differences in pain and analgesia in humans and laboratory animals. The purpose of this study was to investigate the effect of testosterone hormone and spironolactone anti-androgen drug on morphine-induced analgesia in male mice using formalin test.
Methods: In this study, 80 male mice were divided into 10 groups (N=8); normal saline (control), sesame seed oil (as testosterone solvent), testosterone (5 and 10 mg/kg body weight), spironolactone, morphine, sesame seed oil + morphine, testosterone (5 and 10 mg/ kg body weight) + morphine and spironolactone + morphine. Formalin test was performed in all the mice, and data were analyzed by one-way ANOVA.
Results: The results showed that sesame seed oil + morphine (p<0.001), morphine (p<0.001), testosterone (5 mg/kg) + morphine (p<0.01) and testosterone (10 mg/kg) + morphine (p<0.001) significantly reduced acute pain, and testosterone (5 mg/kg) (p<0.05), testosterone (10 mg/kg) (p<0.01), sesame seed oil + morphine (p<0.001), morphine (p<0.001), testosterone (5 mg/kg) + morphine (p<0.001) and testosterone (10 mg/kg) + morphine (p<0.001) significantly reduced chronic pain compared with control group. Spironolactone had no effect on pain relief in the presence and absence of morphine compared to control group.
Conclusions: It can be concluded that testosterone has analgesic effects on the chronic phase of the pain. On the other hand, spironolactone may have hyperalgesic effects due to its anti-androgenic properties.
Samaneh Alijanian, Masoumeh Asle Rousta, Golnaz Asaadi Tehrani, Volume 23, Issue 4 (Winter 2024)
Abstract
Background: Many scientific Researches have shown that diethylnitrosamine, which is used to induce liver carcinoma, has destructive effects on the kidney. Menthol is a monoterpene type with antioxidant, anti-inflammatory, and anti-cancer effects. In the current study, we investigated the effect of menthol on the expression of tumor-related factors and HIF-1α/VEGF signaling in the kidney cells of mice receiving diethylnitrosamine.
Methods: In this research, 16 male mice at the age of 14 days were divided into four groups including Control, Menthol, Nitrosamine, and Nitrosamine-Menthol groups. Nitrosamine and Nitrosamine-Menthol groups received diethyl-nitrosamine intraperitoneally (25 mg/kg) at the age of 14 days. Menthol and Nitrosamine-Menthol groups also received menthol by gavage (50 mg/kg) three times a week for 6 consecutive months. At the end of this period, the expression level of SFRP1, VHL, CTNNB1, HIF-1α, and VEGF in the kidney cells was measured using real-time PCR method.
Results: Menthol treatment caused a significant increase in the expression level of SFRP1 (P=0.021) and VHL (P=0.013) and a significant decrease in the expression level of CTNNB1 (P=0.001), HIF-1α (P=0.000) and VEGF (P=0.000) in the kidney cells of Nitrosamine-Menthol treated group compared to the Nitrosamine group.
Conclusion: The results of this study showed that menthol prevents the decrease in the expression of tumor suppressor factors and the increase in the expression of tumor stimulating factors and factors effective in angiogenesis in the kidney of mice treated with diethyl-nitrosamine, so menthol is probably useful in prevention and treatment of renal cancer.
|
|